During the past decade, The John Bouhasin Center for Children with Bleeding Disorders conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The John Bouhasin Center for Children with Bleeding Disorders" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Hemophilia of Georgia, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The John Bouhasin Center for Children with Bleeding Disorders" are "Bleeding Disorder" (1 trials), "Connective Tissue Disorder" (1 trials), "Haemophilia A Without Inhibitor" (1 trials), "Haemophilia B Without Inhibitor" (1 trials) and "Hematologic Disorder" (1 trials). Many other conditions were trialed in "The John Bouhasin Center for Children with Bleeding Disorders" in a lesser frequency.

The vast majority of trials in "The John Bouhasin Center for Children with Bleeding Disorders" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The John Bouhasin Center for Children with Bleeding Disorders". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The John Bouhasin Center for Children with Bleeding Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The John Bouhasin Center for Children with Bleeding Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".